Innovating Works

LABORATORIO DR. LARRASA

Activa
lncImpact: Long noncoding RNAs Impact on Gene Regulatory Networks WEIZMANN INSTITUTE OF SCIENCE tramitó un H2020: ERC-2019-COG Tens of thousands of loci in mammalian genomes produce long RNAs that do not go on to produce functional proteins, and are collectively call...
2020-01-24 - 2025-11-30 | Financiado
MP-101: a novel drug for prevention and treatment peripheral neuropathy symptoms METYS PHARMACEUTICALS AG tramitó un H2020: H2020-EIC-SMEInst-2018-2020 There will be over 18m new cases of cancer worldwide in 20181, out of which about 3,7m in Europe alone. Studies estimate that up to 40% of a...
2019-01-31 - 2019-04-30 | Financiado
CUSTODIAN: Customized photonic devices for defectless laser based manufacturing ASOC. INVESTIGACION METALURGICA DEL NOROESTE tramitó un H2020: H2020-ICT-2018-20 Different beam shaping technologies, appeared in recent years enable to tailor energy delivery using a tailored spatial and temporal power d...
2018-11-12 - 2022-08-31 | Financiado
SWINE-GEN: Genetic markers assisted selection for improvement of swine breeding productivity. LABORATORIO DR. LARRASA tramitó un H2020: H2020-SMEInst-2014-2015 Laboratorios Dr. Larrasa. S.L is a privately owned biotechnology company founded in 2002. Led by a team of experts in veterinary, genetics a...
2015-09-01 - 2016-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.